Cane Capital Partners’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Sell
2,633
-73
-3% -$22.2K 0.45% 54
2026
Q1
$578K Sell
2,706
-231
-8% -$51.6K 0.25% 69
2025
Q4
$503K Buy
+2,937
New +$457K 0.2% 88

Other funds holding LRCX

Cane Capital Partners's LRCX Position: Q2 2026 in Review

Cane Capital Partners reduced its Lam Research (LRCX) stake by 2.7% in Q2 2026, selling an estimated $22.2K and leaving 2,633 shares worth $1.14M. The position accounts for 0.45% of the portfolio, ranked #54.

Cane Capital Partners first reported a position in LRCX in Q4 2025 and has held it in 3 quarters since. 3,109 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Cane Capital Partners held 2,633 shares of Lam Research worth $1.14M as of Q2 2026.
  • Cane Capital Partners sold 73 Lam Research shares in Q2 2026, an estimated $22.2K.
  • Lam Research made up 0.45% of Cane Capital Partners's portfolio in Q2 2026, its #54 holding.
  • Cane Capital Partners first reported a position in Lam Research in Q4 2025 and has held it in 3 quarters since.
  • 3,109 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Cane Capital Partners's 13F filing for Q2 2026, filed 5 Aug 2026.